HSDT Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- —
- PEG ratio
- 0.00
- P/B
- 0.47
- P/S (TTM)
- 9.74
- EV/EBITDA
- -0.01
Profitability & growth
- ROE (TTM)
- -137.4%
- Operating margin
- -2751.0%
- Revenue growth YoY
- 7290.0%
- Dividend yield
- —
- Beta
- 1.03
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Helius Medical Technologies Inc Class A
Company profileHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Classification
- Sector
- Financial Services
- Industry
- Asset Management
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
